<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36988404</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>Impact of the bacterial nasopharyngeal microbiota on the severity of genus enterovirus lower respiratory tract infection in children: A case-control study.</ArticleTitle><Pagination><StartPage>1728</StartPage><EndPage>1737</EndPage><MedlinePgn>1728-1737</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.26393</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Rhinoviruses (RV) and enteroviruses (EV) are among the main causative etiologies of lower respiratory tract infection (LRTI) in children. The clinical spectrum of RV/EV infection is wide, which could be explained by diverse environmental, pathogen-, and host-related factors. Little is known about the nasopharyngeal microbiota as a risk factor or disease modifier for RV/EV infection in pediatric patients. This study describes distinct nasopharyngeal microbiota profiles according to RV/EV LRTI status in children.</AbstractText><AbstractText Label="METHODS">Cross-sectional case-control study, conducted at Hospital Sant de Déu (Barcelona, Spain) from 2017 to 2020. Three groups of children &lt;5 years were included: healthy controls without viral detection (Group A), mild or asymptomatic controls with RV/EV infection (Group B), and cases with severe RV/EV infection admitted to the pediatric intensive care unit (PICU) (Group C). Nasopharyngeal samples were collected from participants for viral DNA/RNA detection by multiplex-polymerase chain reaction and bacterial microbiota characterization by 16S rRNA gene sequencing.</AbstractText><AbstractText Label="RESULTS">A total of 104 subjects were recruited (A = 17, B = 34, C = 53). Children's nasopharyngeal microbiota composition varied according to their RV/EV infection status. Richness and diversity were decreased among children with severe infection. Nasopharyngeal microbiota profiles enriched in genus Dolosigranulum were related to respiratory health, while genus Haemophilus was specifically predominant in children with severe RV/EV LRTI. Children with mild or asymptomatic RV/EV infection showed an intermediate profile.</AbstractText><AbstractText Label="CONCLUSIONS">These results suggest a close relationship between the nasopharyngeal microbiota and different clinical presentations of RV/EV infection.</AbstractText><CopyrightInformation>© 2023 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penela-Sánchez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5289-6609</Identifier><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Intensive Care Unit, Hospital Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament de Medicina i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocafort</LastName><ForeName>Muntsa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henares</LastName><ForeName>Desiree</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Iolanda</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Intensive Care Unit, Hospital Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament de Medicina i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotons</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrerizo</LastName><ForeName>María</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Enterovirus and Viral Gastroenteritis Unit, Centro Nacional de Microbiología, Instituto Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Launes</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0913-9303</Identifier><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament de Medicina i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Department, Hospital Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muñoz-Almagro</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RDI Microbiology Department, Hospital Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.0.23.196/m9.figshare.19826008</AccessionNumber><AccessionNumber>10.0.23.196/m9.figshare.19825837</AccessionNumber><AccessionNumber>10.0.23.196/m9.figshare.19825249</AccessionNumber><AccessionNumber>10.0.23.196/m9.figshare.19825450</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">intensive care units</Keyword><Keyword MajorTopicYN="N">lower respiratory tract infection</Keyword><Keyword MajorTopicYN="N">microbiota</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36988404</ArticleId><ArticleId IdType="doi">10.1002/ppul.26393</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet. 2021;398(10303):870-905. doi:10.1016/S0140-6736(21)01207-1</Citation></Reference><Reference><Citation>Lauinger IL, Bible JM, Halligan EP, et al. Patient characteristics and severity of human rhinovirus infections in children. J Clin Virol. 2013;58(1):216-220. doi:10.1016/j.jcv.2013.06.042</Citation></Reference><Reference><Citation>Brotons P, Jordan I, Bassat Q, et al. The positive rhinovirus/enterovirus detection and SARS-CoV-2 persistence beyond the acute infection phase: an intra-household surveillance study. Viruses. 2021;13(8):1598. doi:10.3390/v13081598</Citation></Reference><Reference><Citation>Meskill SD, O'Bryant SC. Respiratory virus co-infection in acute respiratory infections in children. Curr Infect Dis Rep. 2020;22(1):3. doi:10.1007/s11908-020-0711-8</Citation></Reference><Reference><Citation>Penela-Sánchez D, González-de-Audicana J, Armero G, et al. Lower respiratory tract infection and genus enterovirus in children requiring intensive care: clinical manifestations and impact of viral co-Infections. Viruses. 2021;13(10):2059. doi:10.3390/v13102059</Citation></Reference><Reference><Citation>Kloepfer KM, Lee WM, Pappas TE, et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol. 2014;133(5):1301-1307.e3. doi:10.1016/j.jaci.2014.02.030</Citation></Reference><Reference><Citation>de Steenhuijsen Piters WAA, Sanders EAM, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond B Biol Sci. 2015;370(1675):20140294. doi:10.1098/rstb.2014.0294</Citation></Reference><Reference><Citation>Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli A. Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children. Drug Healthc Patient Saf. 2014;6:15-20. doi:10.2147/DHPS.S59665</Citation></Reference><Reference><Citation>Allen EK, Koeppel AF, Hendley JO, Turner SD, Winther B, Sale MM. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome. 2014;2:22. doi:10.1186/2049-2618-2-22</Citation></Reference><Reference><Citation>Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(10):1224-1231. doi:10.1164/rccm.201302-0341OC</Citation></Reference><Reference><Citation>Jartti T, Jartti L, Peltola V, Waris M, Ruuskanen O. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J. 2008;27(12):1103-1107. doi:10.1097/INF.0b013e31817e695d</Citation></Reference><Reference><Citation>Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from illumina amplicon data. Nature Methods. 2016;13(7):581-583. doi:10.1038/nmeth.3869</Citation></Reference><Reference><Citation>Cole JR, Wang Q, Fish JA, et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42(Database issue):D633-D642. doi:10.1093/nar/gkt1244</Citation></Reference><Reference><Citation>Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6(1):226. doi:10.1186/s40168-018-0605-2</Citation></Reference><Reference><Citation>McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217</Citation></Reference><Reference><Citation>Oksanen J, Blanchet FG, Kindt R, et al. Package ‘vegan.’ R Package Version 2.0-8. 2013;2:254. https://github.com/vegandevs/vegan</Citation></Reference><Reference><Citation>Lin H, Peddada SD. Analysis of compositions of microbiomes with bias correction. Nat Commun. 2020;11(1):3514. doi:10.1038/s41467-020-17041-7</Citation></Reference><Reference><Citation>Bosch AATM, Piters WAAS, van Houten MA, et al. Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. A prospective cohort study. Am J Respir Crit Care Med. 2017;196(12):1582-1590. doi:10.1164/rccm.201703-0554OC</Citation></Reference><Reference><Citation>Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002-5017. doi:10.1128/JB.00542-10</Citation></Reference><Reference><Citation>Henares D, Brotons P, de Sevilla MF, et al. Differential nasopharyngeal microbiota composition in children according to respiratory health status. Microb Genom. 2021;7(10):000661. doi:10.1099/mgen.0.000661</Citation></Reference><Reference><Citation>Rocafort M, Henares D, Brotons P, et al. Exploring the nasopharyngeal microbiota composition in infants with whooping cough: a test-negative case-control study. PLoS One. 2021;16(10):e0259318. doi:10.1371/journal.pone.0259318</Citation></Reference><Reference><Citation>Sakwinska O, Bastic Schmid V, Berger B, et al. Nasopharyngeal microbiota in healthy children and pneumonia patients. J Clin Microbiol. 2014;52(5):1590-1594. doi:10.1128/JCM.03280-13</Citation></Reference><Reference><Citation>Chen M, He S, Miles P, et al. Nasal bacterial microbiome differs between healthy controls and those with asthma and allergic rhinitis. Front Cell Infect Microbiol. 2022;12:841995. doi:10.3389/fcimb.2022.841995</Citation></Reference><Reference><Citation>Camelo-Castillo A, Henares D, Brotons P, et al. Nasopharyngeal microbiota in children with invasive pneumococcal disease: identification of bacteria with potential disease-promoting and protective effects. Front Microbiol. 2019;10:11. doi:10.3389/fmicb.2019.00011</Citation></Reference><Reference><Citation>Lappan R, Imbrogno K, Sikazwe C, et al. A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera. BMC Microbiol. 2018;18(1):13. doi:10.1186/s12866-018-1154-3</Citation></Reference><Reference><Citation>Mokoena MP. Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules. 2017;22(8):1255. doi:10.3390/molecules22081255</Citation></Reference><Reference><Citation>Hasegawa K, Linnemann RW, Mansbach JM, et al. Nasal airway microbiota profile and severe bronchiolitis in infants: a case-control study. Pediatr Infect Dis J. 2017;36(11):1044-1051. doi:10.1097/INF.0000000000001500</Citation></Reference><Reference><Citation>Kaul D, Rathnasinghe R, Ferres M, et al. Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection. Nat Commun. 2020;11(1):2537. doi:10.1038/s41467-020-16429-9</Citation></Reference><Reference><Citation>Cremers AJ, Zomer AL, Gritzfeld JF, et al. The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition. Microbiome. 2014;2:44. doi:10.1186/2049-2618-2-44</Citation></Reference><Reference><Citation>De Boeck I, Wittouck S, Wuyts S, et al. Comparing the healthy nose and nasopharynx microbiota reveals continuity as well as niche-specificity. Front Microbiol. 2017;8:2372. doi:10.3389/fmicb.2017.02372</Citation></Reference><Reference><Citation>Bomar L, Brugger SD, Yost BH, Davies SS, Lemon KP. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio. 2016;7(1):e01725-15. doi:10.1128/mBio.01725-15</Citation></Reference><Reference><Citation>Brugger SD, Eslami SM, Pettigrew MM, et al. Dolosigranulumpigrum cooperation and competition in human nasal microbiota. mSphere. 2020;5(5):e00852-20. doi:10.1128/mSphere.00852-20</Citation></Reference><Reference><Citation>de Steenhuijsen Piters WAA, Jochems SP, Mitsi E, et al. Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine. Nat Commun. 2019;10(1):2981. doi:10.1038/s41467-019-10814-9</Citation></Reference><Reference><Citation>Ortiz Moyano R, Raya Tonetti F, Tomokiyo M, et al. The ability of respiratory commensal bacteria to beneficially modulate the lung innate immune response is a strain dependent characteristic. Microorganisms. 2020;8(5):727. doi:10.3390/MICROORGANISMS8050727</Citation></Reference><Reference><Citation>Raya Tonetti F, Tomokiyo M, Ortiz Moyano R, et al. The respiratory commensal bacterium Dolosigranulum pigrum 040417 improves the innate immune response to Streptococcus pneumoniae. Microorganisms. 2021;9(6):1324. doi:10.3390/MICROORGANISMS9061324</Citation></Reference><Reference><Citation>Hyde ER, Petrosino JF, Piedra PA, Camargo CA, Jr., Espinola JA, Mansbach JM. Nasopharyngeal proteobacteria are associated with viral etiology and acute wheezing in children with severe bronchiolitis. J Allergy Clin Immunol. 2014;133(4):1220-1222.e3. doi:10.1016/j.jaci.2013.10.049</Citation></Reference><Reference><Citation>Teo SM, Mok D, Pham K, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704-715.</Citation></Reference><Reference><Citation>Rosas-Salazar C, Shilts MH, Tovchigrechko A, et al. Nasopharyngeal microbiome in respiratory syncytial virus resembles profile associated with increased childhood asthma risk. Am J Respir Crit Care Med. 2016;193(10):1180-1183. doi:10.1016/j.chom.2015.03.008</Citation></Reference><Reference><Citation>Langevin S, Pichon M, Smith E, et al. Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. J Gen Virol. 2017;98(10):2425-2437. doi:10.1099/jgv.0.000920</Citation></Reference><Reference><Citation>Hofstra JJ, Matamoros S, van de Pol MA, et al. Changes in microbiota during experimental human rhinovirus infection. BMC Infect Dis. 2015;15:336. doi:10.1186/s12879-015-1081-y</Citation></Reference><Reference><Citation>Toivonen L, Camargo CA, Jr., Gern JE, et al. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J Allergy Clin Immunol. 2019;143(5):1925-1928.e7. doi:10.1016/j.jaci.2018.12.1004</Citation></Reference><Reference><Citation>Mansbach JM, Hasegawa K, Piedra PA, et al. Haemophilus-dominant nasopharyngeal microbiota is associated with delayed clearance of respiratory syncytial virus in infants hospitalized for bronchiolitis. J Infect Dis. 2019;219(11):1804-1808. doi:10.1093/infdis/jiy741</Citation></Reference><Reference><Citation>de SteenhuijsenPiters WAA, Heinonen S, Hasrat R, et al. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med. 2016;194(9):1104-1115. doi:10.1164/rccm.201602-0220OC</Citation></Reference><Reference><Citation>Mika M, Maurer J, Korten I, et al. Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study. Microbiome. 2017;5(1):85. doi:10.1186/s40168-017-0302-6</Citation></Reference><Reference><Citation>Biesbroek G, Wang X, Keijser BJF, et al. Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerging Infect Dis. 2014;20(2):201-210. doi:10.3201/eid2002.131220</Citation></Reference><Reference><Citation>Marsh RL, Smith-Vaughan HC, Chen ACH, et al. Multiple respiratory microbiota profiles are associated with lower airway inflammation in children with protracted bacterial bronchitis. Chest. 2019;155(4):778-786. doi:10.1016/j.chest.2019.01.002</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>